We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
678

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.15%
2 Financials 9.51%
3 Healthcare 7.52%
4 Consumer Discretionary 6.79%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
3726
Praxis Precision Medicines
PRAX
$10.5B
$645K ﹤0.01%
18,937
+12,475
+193% +$622K
LPG icon
3727
Dorian LPG
LPG
$2.05B
$644K ﹤0.01%
47,421
+13,971
+42% +$210K
MC icon
3728
Moelis & Co
MC
$4.98B
$644K ﹤0.01%
19,039
+12,123
+175% +$508K
MYRG icon
3729
MYR Group
MYRG
$4.87B
$644K ﹤0.01%
7,596
-100
-1% -$9.16K
WELL icon
3730
CALL
Welltower
WELL
$174B
$643K ﹤0.01%
10,000
KALV
3731
DELISTED
KalVista Pharmaceuticals
KALV
$642K ﹤0.01%
44,269
-10,707
-19% -$150K
PFTA
3732
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$641K ﹤0.01%
65,049
+4
+0% +$39
CNOB icon
3733
Center Bancorp
CNOB
$1.61B
$638K ﹤0.01%
27,663
+5,153
+23% +$132K
EXFY icon
3734
Expensify
EXFY
$233M
$638K ﹤0.01%
42,900
-30,989
-42% -$578K
CLLS
3735
Cellectis
CLLS
$344M
$637K ﹤0.01%
278,327
+6,778
+2% +$20.5K
MAC icon
3736
PUT
Macerich
MAC
$6.86B
$635K ﹤0.01%
80,000
PAAS icon
3737
PUT
Pan American Silver
PAAS
$21.8B
$635K ﹤0.01%
40,000
ORGO icon
3738
Organogenesis Holdings
ORGO
$225M
$631K ﹤0.01%
194,778
+43,523
+29% +$197K
ZNTL icon
3739
Zentalis Pharmaceuticals
ZNTL
$368M
$631K ﹤0.01%
29,112
-25,633
-47% -$701K
BV icon
3740
BrightView Holdings
BV
$1.02B
$630K ﹤0.01%
79,326
+22,455
+39% +$240K
CROX icon
3741
Crocs
CROX
$5.93B
$630K ﹤0.01%
9,170
-262,460
-97% -$18.2M
NOTV
3742
DELISTED
Inotiv
NOTV
$624K ﹤0.01%
37,061
-6,843
-16% -$126K
QCRH icon
3743
QCR Holdings
QCRH
$1.65B
$622K ﹤0.01%
12,205
+6,774
+125% +$379K
BXC icon
3744
PUT
BlueLinx
BXC
$651M
$621K ﹤0.01%
10,000
-10,000
-50% -$721K
WSO icon
3745
Watsco Inc
WSO
$13B
$621K ﹤0.01%
2,411
+356
+17% +$96.5K
DLTH icon
3746
Duluth Holdings
DLTH
$142M
$620K ﹤0.01%
87,967
+10,174
+13% +$90.9K
AD
3747
Array Digital Infrastructure
AD
$3.08B
$620K ﹤0.01%
23,826
-7,483
-24% -$214K
CTRA
3748
PUT
DELISTED
Coterra Energy
CTRA
$619K ﹤0.01%
+23,700
New +$679K
ASAN icon
3749
CALL
Asana
ASAN
$2.18B
$618K ﹤0.01%
27,800
+17,800
+178% +$382K
ORI icon
3750
Old Republic International
ORI
$10.2B
$617K ﹤0.01%
29,475
+2,996
+11% +$67.4K

Similar funds

David Shaw's Q3 2022 Portfolio in Review

As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, David Shaw opened a new position in Prologis worth $66.1M.

  • David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
  • David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • David Shaw opened 545 new positions and closed 678 in Q3 2022.
  • David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.